Figure 1.

Overview of the most common EIM and their biological, small-molecule treatment options. EIM, extraintestinal manifestation; IL, interleukin; JAK, Januskinase; TNF, tumour necrosis factor; Vedo, vedolizumab.

Overview of the most common EIM and their biological, small-molecule treatment options. EIM, extraintestinal manifestation; IL, interleukin; JAK, Januskinase; TNF, tumour necrosis factor; Vedo, vedolizumab.